Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sara Pezzatti
Observed names:
Pezzatti S,
S. Pezzatti
Institution:
Azienda Ospedaliera San Gerardo
Observed institutions:
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino,
Azienda Ospedaliera San Gerardo,
Fondazione Gimema Onlus,
Istituti di Ricovero e Cura a Carattere Scientifico,
University of Turin,
University of Milano-Bicocca
show all 6
ORCID:
0000-0002-3598-6135
Observed ORCID:
0000-0002-3598-6135
OpenAlex ID:
A5090123367
Autologous Transplantation and Maintenance Therapy in Multiple Myeloma
2014
·
Antonio Palumbo
, Federica Cavallo
, et al.
·
New England Journal of Medicine
·
844
PDF
Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide
2011
·
Alessandra Larocca
, Federica Cavallo
, et al.
·
Blood
·
303
Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma
2015
·
Antonio Palumbo
, Francesca Gay
, et al.
·
Journal of Clinical Oncology
·
157
Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results
2013
·
Francesca Gay
, Valeria Magarotto
, et al.
·
Blood
·
85
PDF
Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials
2012
·
A. Palumbo
, A. Waage
, et al.
·
Haematologica
·
76
PDF
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial
2022
·
Meletios A Dimopoulos
, Paul G Richardson
, et al.
·
The Lancet Haematology
·
54
PDF
Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial
2019
·
Sara Bringhen
, Mattia D’Agostino
, et al.
·
Haematologica
·
44
Peripheral Blood Lymphocyte/Monocyte Ratio Predicts Outcome in Follicular Lymphoma and in Diffuse Large B-Cell Lymphoma Patients in the Rituximab Era
2014
·
Angelo Belotti
, Elisa Doni
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
44
Melphalan/Prednisone/Lenalidomide (MPR) Versus High-Dose Melphalan and Autologous Transplantation (MEL200) in Newly Diagnosed Multiple Myeloma (MM) Patients <65 Years: Results of a Randomized Phase III Study
2011
·
Antonio Palumbo
, Federica Cavallo
, et al.
·
Blood
·
24
A fatal case of TEMPI syndrome, refractory to proteasome inhibitors and autologous stem cell transplantation
2020
·
Elisa Diral
, Matteo Parma
, et al.
·
Leukemia Research
·
17
Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials
2018
·
Mattia D’Agostino
, Lorenzo De Paoli
, et al.
·
Critical Reviews in Oncology/Hematology
·
17
PDF
Bortezomib, Cyclophosphamide, Dexamethasone Versus Lenalidomide, Cyclophosphamide, Dexamethasone in Multiple Myeloma Patients at First Relapse
2018
·
Vittorio Montefusco
, Alessandro Corso
, et al.
·
British Journal of Haematology
·
16
Anti-BCMA CAR-T cell-based therapies and bispecific antibodies in the immunotherapy era: are we ready for this?
2024
·
Massimo Martino
, Barbara Gamberi
, et al.
·
Expert Review of Hematology
·
11
Implemented myeloma management with whole-body low-dose CT scan: a real life experience
2016
·
Silvia Mangiacavalli
, Sara Pezzatti
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
11
A Phase III Study to Compare Melphalan, Prednisone, Lenalidomide (MPR) Versus Melphalan 200 Mg/m2 and Autologous Transplantation (MEL200) In Newly Diagnosed Multiple Myeloma Patients
2010
·
Antonio Palumbo
, Federica Cavallo
, et al.
·
Blood
·
9
Lenalidomide-based triplet regimens in first relapsed multiple myeloma patients: real-world evidence from a propensity score matched analysis
2022
·
Silvia Mangiacavalli
, Claudio Salvatore Cartia
, et al.
·
Haematologica
·
7
Impact of the Addition of Daratumumab to the Standard Bortezomib-Thalidomide-Dexamethasone Regimen on Hematopoietic Stem Cell Mobilization and Collection, Post-Transplant Engraftment and Infectious Complications: A Case-Control Multicentre Real-Life Analysis
2023
·
Gianluca Cavallaro
, Monica Galli
, et al.
·
Blood
·
5
PDF
Refining the role of selinexor in multiple myeloma: strategic use in a shifting treatment landscape
2026
·
F. Gay
, G. Buda
, et al.
·
ESMO Open
·
4
PDF
S300: Health-related Quality of Life in Transplant-ineligible Real-life Multiple Myeloma Patients Treated With Bortezomib-melphalan-prednisone (vmp) Vs. Lenalidomide-dexamethasone (rd)
2022
·
M. D’Agostino
, S. Bringhen
, et al.
·
HemaSphere
·
3
Bortezomib/Cyclophosphamide/Dexamethasone Versus Lenalidomide/Cyclophosphamide/Dexamethasone in Multiple Myeloma Patients at First Relapse: Final Results of a Phase III Study
2017
·
Vittorio Montefusco
, Alessandro Corso
, et al.
·
Blood
·
3
Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab‐, Elotuzumab‐, and Carfilzomib‐Based Triplet Regimens: A Multicenter Real‐World Analysis of 635 Patients
2025
·
Fortunato Morabito
, Enrica Antonia Martino
, et al.
·
European Journal Of Haematology
·
2
Feasibility and effectiveness of the prolonged use of eltrombopag in addition to immunosuppression in patients with acquired aplastic anemia: a single-center real-life experience
2024
·
Monica Carpenedo
, Arianna Zappaterra
, et al.
·
Platelets
·
2
Characteristics of 15 Subjects Affected by IgD Multiple Myeloma and the Key Role of the Laboratory in Diagnosis: A Retrospective Study Report and Literature Review
2024
·
Jari Intra
, Sara Pezzatti
, et al.
·
International Journal of Translational Medicine
·
2
IgD multiple myeloma: The relevant clinical role of laboratory in the detection of rare plasma cell neoplasms
2022
·
Jari Intra
, Adele Cappellani
, et al.
·
The American Journal of the Medical Sciences
·
2
Salvage Autologous Stem Cell Transplant for the Treatment of First Relapse Multiple Myeloma: Evidence of Its Clinical Role from a Multicenter Italian Study
2023
·
Silvia Mangiacavalli
, Daniele Derudas
, et al.
·
Blood
·
1
Show more works
View as search
Works count:
40
Citation count:
1,745
H-index:
12
I10-index:
14
Year
Topic
Type